TW200911991A - Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori - Google Patents

Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori Download PDF

Info

Publication number
TW200911991A
TW200911991A TW96134230A TW96134230A TW200911991A TW 200911991 A TW200911991 A TW 200911991A TW 96134230 A TW96134230 A TW 96134230A TW 96134230 A TW96134230 A TW 96134230A TW 200911991 A TW200911991 A TW 200911991A
Authority
TW
Taiwan
Prior art keywords
helicobacter pylori
vector
antibody
igy
pylori
Prior art date
Application number
TW96134230A
Other languages
English (en)
Chinese (zh)
Other versions
TWI358454B (es
Inventor
Gan-Nan Chang
Original Assignee
Gan-Nan Chang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gan-Nan Chang filed Critical Gan-Nan Chang
Priority to TW96134230A priority Critical patent/TW200911991A/zh
Publication of TW200911991A publication Critical patent/TW200911991A/zh
Application granted granted Critical
Publication of TWI358454B publication Critical patent/TWI358454B/zh

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
TW96134230A 2007-09-13 2007-09-13 Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori TW200911991A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW96134230A TW200911991A (en) 2007-09-13 2007-09-13 Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW96134230A TW200911991A (en) 2007-09-13 2007-09-13 Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori

Publications (2)

Publication Number Publication Date
TW200911991A true TW200911991A (en) 2009-03-16
TWI358454B TWI358454B (es) 2012-02-21

Family

ID=44724759

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96134230A TW200911991A (en) 2007-09-13 2007-09-13 Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori

Country Status (1)

Country Link
TW (1) TW200911991A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117050168A (zh) * 2023-08-14 2023-11-14 苏州东抗生物科技有限公司 抗幽门杆菌UreA蛋白的单克隆抗体及其应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117050168A (zh) * 2023-08-14 2023-11-14 苏州东抗生物科技有限公司 抗幽门杆菌UreA蛋白的单克隆抗体及其应用
CN117050168B (zh) * 2023-08-14 2024-03-01 苏州东抗生物科技有限公司 抗幽门杆菌UreA蛋白的单克隆抗体及其应用

Also Published As

Publication number Publication date
TWI358454B (es) 2012-02-21

Similar Documents

Publication Publication Date Title
Roberts et al. Pathogen, host and environmental factors contributing to the pathogenesis of listeriosis
Dubreuil et al. Animal enterotoxigenic Escherichia coli
Freter Mechanisms of association of bacteria with mucosal surfaces
AU2020218748B2 (en) A genetically modified lactobacillus and uses thereof
Actis et al. Vibriosis.
Lopes et al. Virulence factors of foodborne pathogen Campylobacter jejuni
Malik-Kale et al. Characterization of genetically matched isolates of Campylobacter jejuni reveals that mutations in genes involved in flagellar biosynthesis alter the organism's virulence potential
KR20080080069A (ko) 독성 유전자, 단백질, 및 그 용도
TWI328035B (en) Anti-bacterial vaccine compositions
TW201113373A (en) A cytolytic RTX-toxin from gallibacterium anatis
Godlewska et al. Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs
JP4112011B2 (ja) Ｈｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉアドヘシン結合型抗原
KIM et al. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits
EP4007600A1 (en) Vaccine compositions and methods of selecting antigens
BRPI0708959A2 (pt) genes e proteìnas de brachyspira hyodysenteriae e uso dos mesmos para diagnóstico e terapia
TW200911991A (en) Manufacturing method and application of antibody IgY derived from the recombinant ureA and ureB vaccine of Helicobacter pylori
Vyas et al. Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization
JPH11511032A (ja) ＩｃｅＡ遺伝子および関連法
US7732580B2 (en) Compositions for eliciting an immune response against Mycobacterium avium subspecies paratuberculosis
PL199497B1 (pl) Wyizolowany polipeptyd, jego immunogenny fragment, wyizolowany polinukleotyd, wektor ekspresyjny, komórka gospodarza, błona komórki gospodarza, sposób wytwarzania polipeptydu lub immunogennego fragmentu, sposób wyrażania polinukleotydu, kompozycja szczepionki, przeciwciało, zastosowanie kompozycji zawierającej polipeptyd, zastosowanie kompozycji zawierającej polinukleotyd, kompozycja terapeutyczna oraz sposób diagnozowania zakażenia Moraxella catarrhalis
TW201934139A (zh) 用於治療或預防癌症之組合療法
Alarjani Investigation of the Influence of Phase Variation on the Biological Phenotypes and Immunity to the Flagella in Campylobacter jejuni
Naz Reinvestigation into the mechanisms of Campylobacter jejuni invasion of intestinal epithelial cells
Macbeth The Role of the Gut Microbiome in Shaping Immune Responses to Vibrio cholerae
Kazemi-Roudsari et al. Design of an oral vaccine using Lactococcus lactis against brucellosis: an in vitro and in vivo study

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees